National Health (Supplies of out-patient medication) Amendment Determination 2020
PB 41 of 2020
___________________________________________________________________________
I, Thea Daniel, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this instrument.
Dated 29 April 2020
Thea Daniel
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
___________________________________________________________________________
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
National Health (Supplies of out-patient medication) Determination 2019 (No. 2)
This instrument is the National Health (Supplies of out-patient medication) Amendment Determination 2020. This Determination may also be cited as PB 41 of 2020.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | The day after registration. | The day after registration. |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under section 84BA of the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
National Health (Supplies of out-patient medication) Determination 2019 (No. 2)
1 Section 5(1) after the definition of approved ex-manufacturer price
Repeal the definition of National Health Reform Agreement.
2 Section 5(1) after the definition of out-patient medication
Insert Pharmaceutical Reform Arrangements means arrangements which provide for public hospitals that are Approved Hospital Authorities under Section 94 of the National Health Act 1953 to supply pharmaceuticals funded by the PBS for specific categories of patients including:
3 Subsection 8(2)(b)
Repeal the paragraph, substitute:
(b) a public hospital that is participating in Pharmaceutical Reform Arrangements.
4 Subsection 10(1)
Repeal the paragraph, substitute:
(1) This section applies to supplies of out-patient medication made by a public hospital that is participating in Pharmaceutical Reform Arrangements, except if the public hospital is located in the State of Queensland.